Sponsored by:

Nuclear Medicine: Page 373

Draxis notches upbeat Q1
By AuntMinnie.com staff writers
Strong growth in contract manufacturing and an uptick in radiopharmaceutical sales fueled a surge in first-quarter revenues for Draxis Health of Mississauga, Ontario.
May 11, 2005
Medx inks Yale distribution deal
By AuntMinnie.com staff writers
Nuclear imaging systems manufacturer Medx has signed a deal with Yale University of New Haven, CT, to be its sole worldwide distributor for a cardiac quantification application, Wackers-Liu CQ.
May 10, 2005
Palatin reports higher sales, lower net loss
By AuntMinnie.com staff writers
Radiopharmaceutical developer Palatin Technologies reported a big gain in revenues and a lower net loss for the company's fiscal third quarter (end-March 31).
May 9, 2005
Cytogen revenues up in Q1, but loss widens
By AuntMinnie.com staff writers
Biopharmaceutical firm Cytogen reported first-quarter total product revenues of $4 million, up 10% compared with the $3.6 million posted last year.
May 4, 2005
BrachySil data to debut at ESTRO
By AuntMinnie.com staff writers
Biomedical nanotechnology firm pSivida of Perth, Australia, said that current data from its BrachySil cancer therapy product investigational trials will be presented at the European Society for Therapeutic and Radiation Oncology (ESTRO) conference in Budapest, Hungary, this week.
May 3, 2005
Digirad revenues rise, but loss widens in Q1
By AuntMinnie.com staff writers
Nuclear medicine vendor Digirad reported first-quarter revenues of $18 million, up 13% compared with the $15.9 million turned in during the first quarter of 2004.
May 2, 2005
Gamma-based imaging proves useful in breast cancer metastases
By Shalmali Pal
Two recent studies have taken a closer look at the role of gamma cameras and gamma probes in tracking the spread of breast cancer. In the first study, Japanese researchers compared SPECT to FDG-PET for detecting bone metastasis to the axial skeleton in breast cancer cases. In the second paper, French authors compared gamma probes for sentinel lymph node detection, which is an important guide for therapeutic choices.
April 28, 2005
2005 04 25 09 49 44 706
Immunomedics to raise $36 million
By AuntMinnie.com staff writers
Radiopharmaceutical firm Immunomedics said it has signed definitive agreements to complete approximately $36 million in financing through the issuance of senior convertible notes and common stock warrants.
April 27, 2005
Draxis names president of radiopharmaceuticals group
Draxis Health of Mississauga, Ontario, has selected Jean-Pierre Robert as the new president of its radiopharmaceuticals division in Montreal.
April 26, 2005
More PET/CT lung masses seen with hardware-based fusion
By Eric Barnes
Two new studies underscore the superiority of PET/CT for imaging lung lesions compared to either modality alone. The first found that different fusion methods produce substantially different results, while the second found that PET/CT has higher sensitivity, specificity, and positive and negative predictive values than either modality alone for detecting lung metastases.
April 25, 2005
2005 04 25 15 10 14 706
AuntMinnie.com Molecular Imaging Radiology Insider
By Jonathan S. Batchelor
April 24, 2005
PET/CT market on the rise
By AuntMinnie.com staff writers
The U.S. PET and PET/CT markets produced revenue of $496.6 million in 2004, according to a new report from market research firm Frost & Sullivan.
April 24, 2005
Previous Page
Page 373 of 440
Next Page